Antioxidant activity of calcium channel blocking drugs.
Mak
I T
IT
Department of Medicine, George Washington University Medical Center, Washington, D.C. 20037.
Weglicki
W B
WB
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001011:Aorta; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004110:Diltiazem / Q000494:pharmacology; D004285:Dogs; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D005609:Free Radicals; D005978:Glutathione / Q000378:metabolism*; D006352:Heart Ventricles; D007536:Isomerism; D007700:Kinetics; D015227:Lipid Peroxidation / Q000187:drug effects*; D008315:Malondialdehyde / Q000032:analysis; D009206:Myocardium / Q000378:metabolism*; D009529:Nicardipine / Q000494:pharmacology; D009543:Nifedipine / Q000494:pharmacology; D012508:Sarcolemma / Q000187:drug effects / Q000378:metabolism*; D014700:Verapamil / Q000494:pharmacology
D000975:Antioxidants; D002121:Calcium Channel Blockers; D005609:Free Radicals; D008315:Malondialdehyde; D014700:Verapamil; D009529:Nicardipine; D004110:Diltiazem; D005978:Glutathione; D009543:Nifedipine